Home > Diseases and Conditions > Gilles de la Tourette syndrome
Bookmark and Share

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

A.D.A.M. Medical Encyclopedia. Atlanta (GA): A.D.A.M.; 2011.

A.D.A.M. Medical Encyclopedia.

Gilles de la Tourette syndrome

Tourette syndrome

Last reviewed: February 5, 2011.

Gilles de la Tourette syndrome is a condition that causes people to make repeated, quick movements or sounds that they cannot control. These movements or sounds are called tics.

The condition is commonly called Tourette syndrome.

See also:

Causes, incidence, and risk factors

Tourette syndrome is named for Georges Gilles de la Tourette, who first described this disorder in 1885. There is strong evidence that Tourette syndrome is passed down through families, although the gene has not yet been found.

The syndrome may be linked to problems in certain areas of the brain. It may have to do with chemical substances (dopamine, serotonin, and norepinephrine) that help nerve cells talk to one another.

Tourette syndrome can be either severe or mild. About 10% of Americans have a mild tic disorder. Far fewer people have more severe forms of Tourette syndrome. Many people with very mild tics may not be aware of them and never seek medical help.

Tourette syndrome is four times as likely to occur in boys as in girls.

Symptoms

Most people with Tourette syndrome first notice symptoms during childhood, between ages 7 and 10.

The most common first symptom is a tic of the face, but other tics may follow. A tic is a sudden, fast, repeated movement or sound.

Symptoms of Tourette syndrome can range from tiny, minor movements (such as grunts, sniffling, or coughing) to constant movements and sounds that can't be controlled.

Tics can include:

  • Arm thrusting

  • Eye blinking

  • Jumping

  • Kicking

  • Repeated throat clearing or sniffing

  • Shoulder shrugging

Tics may occur many times a day, but they tend to improve or get worse at different times. The tics may change with time. Symptoms usually get worse before the mid-teen years.

Contrary to popular belief, only a small number of patients use curse words or other inappropriate words or phrases (coprolalia).

Tourette syndrome is different from obsessive-compulsive disorder (OCD). People with OCD feel as though they have to do the behaviors.

Many people with Tourette syndrome can stop doing the tic for periods of time. However, they find that the tic is stronger for a few minutes after they allow it to start again. Often the tic slows or stops during sleep.

Signs and tests

There are no lab tests to diagnose Tourette syndrome. However, a health care provider should do an examination to rule out other causes of the symptoms.

To be diagnosed with Tourette syndrome, a person must:

  • Have had many motor tics and one or more vocal tics, although these tics may not have occurred at the same time

  • Have tics that occur many times a day, nearly every day or on and off, for a period of more than 1 year. During this period, there must not have been a tic-free period of more than 3 months in a row.

  • Have started the tics before age 18

  • Have no other brain problem that could be a likely cause of the symptoms

Treatment

Many patients with Tourette syndrome who have very minor symptoms are not treated, because the side effects of the medications may be worse than the symptoms of Tourette syndrome.

Drugs used to treat tics include:

  • Antiseizure medications

  • Blood pressure medicine called clonidine

  • Botulinum toxin injections (can control some motor tics)

  • Dopamine blockers, such as fluphenazine, haloperidol, pimozide and risperidone (can help control or reduce tics, but they have side effects)

Deep brain stimulation has shown promise for treating both the main symptoms of Tourette syndrome and the obsessive-compulsive behaviors.

Support Groups

Tourette Syndrome Association - www.tsa-usa.org

Expectations (prognosis)

Symptoms usually peak during the teenage years and then improve in early adulthood. Although 1 in 4 patients may be symptom-free for a few years, only 8% of symptoms go away without returning.

Patients usually have normal intelligence and live a normal-length life.

Complications

Conditions that may occur in people who have Tourette syndrome include:

These conditions need to be diagnosed and treated.

Calling your health care provider

Make an appointment with your health care provider if you have tics that are severe or persistent, or if they interfere with your daily life.

Prevention

There is no known prevention.

References

  1. Gleason MM, Boris NW, Dalton R. Habit and tic disorders. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 23.
  2. Jankovic J, Lang AE. Movement disorders: diagnosis and assessment. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, eds. Neurology in Clinical Practice. 5th ed. Philadelphia, Pa: Butterworth-Heinemann Elsevier; 2008:chap 23.
  3. Lang A. Other movement disorders. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 434.
  4. Kurlan R. Clinical practice Tourette's Syndrome. N Engl J Med. 2010;363(24):2332-2338.

Review Date: 2/5/2011.

Reviewed by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Joseph V. Campellone, MD, Division of Neurology, Cooper University Hospital, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Copyright © 2012, A.D.A.M., Inc.

What works?

  • Cannabinoids for Tourette syndrome Cannabinoids for Tourette syndrome
    Cannabinoid medication might be useful in the treatment of the symptoms in patients with Tourette's syndrome. At the present time only two relevant studies have been conducted. Both studies used tetrahydrocannabinol (Δ9THC). In both studies Δ9THC was associated with tic reduction. However the sample size was small and a large number of multiple comparisons were made . There were only 28 participants in total, since eight participants took part in both studies. Possibly the patients who derived the greatest benefit and experienced the least adverse effects would be the most inclined to participate in further studies. There were a high number of drop outs/exclusions in the six week study and it is unclear whether intention to treat analysis (ITT) was performed. The results that are reported are analyses done on the patients who remained in the study on the study medication at the correct dose. In reality, patients do opt not to continue treatment if there is limited efficacy or unpalatable side effects. This introduces attrition bias. Whilst there were some significant results, the authors themselves accept that very few of these results are significant if a Bonferroni correction is performed. It is possible that cannabinoid medication has a beneficial effect which is too weak to be detected using ITT and such a small sample size. There is some weak evidence that cannabinoid medication may have an effect on obsessive compulsive behaviour but the measure used was an addition to the TSSL which has not been validated.There were no data on the effect of Δ9THC on quality of life.There is not enough evidence to support the use of cannabinoids in treating tics and obsessive compulsive behaviour in people with Tourette's syndrome.
See all (2)...

Learn about...

  • How we know if a treatment works How we know if a treatment works
    Testing Treatments is a lively look at modern clinical research, and how everyone can get involved in using and improving research for better health care.

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...